TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

MACROGENICS INC

OncologyGastroenterologyInfectious Disease
Biotech

MACROGENICS INC is a biotechnology company focused on Oncology, Gastroenterology, Infectious Disease.

2020
Since
1
Drugs
-
Trials
1
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

MARGENZA 2025-01-15
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 82%
1 drugs Phase 3: 1 Phase 2: 6 Phase 1: 14
Gastroenterology 9%
0 drugs Phase 2: 1 Phase 1: 2
Infectious Disease 5%
0 drugs Phase 1: 2
Immunology 2%
0 drugs Phase 1: 1
Metabolic 2%
0 drugs Phase 1: 1

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Oncology, Infectious Disease, Immunology, Gastroenterology
Merck big-pharma
Oncology, Infectious Disease, Immunology, Metabolic
Johnson & Johnson big-pharma
Oncology, Immunology, Infectious Disease, Metabolic
Sanofi big-pharma
Metabolic, Oncology, Infectious Disease, Immunology
Bristol-Myers Squibb big-pharma
Oncology, Immunology, Gastroenterology, Infectious Disease